Skip to main content
Top
Published in: Clinical Rheumatology 2/2008

01-02-2008 | Original Article

Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren’s syndrome

Authors: Peter Szodoray, Katalin Koczok, Antonia Szanto, Ildiko Fanny Horvath, Britt Nakken, Ildiko Molnar, Margit Zeher

Published in: Clinical Rheumatology | Issue 2/2008

Login to get access

Abstract

Sjögren’s syndrome (SS) is a prototypical systemic autoimmune disease, where autoimmune processes lead to the dysfunction of the exocrine glands. The key feature of the disease is autoimmune exocrinopathy, causing reduced tear secretion and subsequent keratoconjunctivitis sicca (KCS). The aim of this study was to investigate the connection between the presence of autoantibodies to lachrymal gland antigens and the reduced tear production in patients with primary SS. Ninety-nine patients, 90 women and 9 men, were investigated in the study. Twenty healthy young women served as controls. Enzyme-linked immunosorbent assay (ELISA) and Western blotting were applied to detect autoantibodies to antigen fractions prepared from the human lachrymal gland membrane and cytosolic fractions. Autoantibodies of the IgG, IgA and IgM isotypes to the lachrymal membrane and cytosolic fractions were detected in about one third (27%) of the patients with primary SS. IgA antobodies to the membrane and cytosolic fractions occurred most frequently in SS patients. A significant difference was found in the presence of IgA antibodies to the membrane lachrymal fraction between patients and controls given in ELISA indices (1.23 ± 0.3 vs 1 ± 0.19, p < 0.001). IgG, IgA, and IgM isotypes of autoantibodies directed to the membrane lachrymal fraction of 200–180, 120–116, 80–70, 58, 50, 48.5, 40 and 28.8 kDa were also identified in patients. Membrane IgG antibody levels showed a positive correlation (R = 0.998; p = 0.045) with the clinical loss of secretory function (Schirmer’s test values). Positive correlation was found between membrane IgM and anti-SS-A levels (R = 0.962; p = 0.038) and also between cytosolic IgM antibodies and anti-SS-A levels (R = 0.982; p = 0.018). IgG, IgA and IgM types of autoantibodies may play a role in the development of the impaired lachrymal secretion and therefore may be involved in the pathogenesis of KCS.
Literature
2.
go back to reference Jonsson R, Brokstad K (2001) Sjögren’s syndrome. In: Austen F, Atkinson C (eds) Samter’s immunologic diseases, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 495–504 Jonsson R, Brokstad K (2001) Sjögren’s syndrome. In: Austen F, Atkinson C (eds) Samter’s immunologic diseases, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 495–504
3.
go back to reference Tengner P, Halse AK, Haga HJ et al (1998) Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren’s syndrome. Arthritis Rheum 41:2238–2248PubMedCrossRef Tengner P, Halse AK, Haga HJ et al (1998) Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren’s syndrome. Arthritis Rheum 41:2238–2248PubMedCrossRef
4.
go back to reference Kino-Ohsaki J, Nishimori I, Morita M et al (1996) Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren’s syndrome. Gastroenterology 110:1579–1586PubMedCrossRef Kino-Ohsaki J, Nishimori I, Morita M et al (1996) Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren’s syndrome. Gastroenterology 110:1579–1586PubMedCrossRef
5.
go back to reference Feist E, Kuckelkorn U, Dorner T et al (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42:697–702PubMedCrossRef Feist E, Kuckelkorn U, Dorner T et al (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42:697–702PubMedCrossRef
6.
go back to reference Haneji N, Nakamura T, Takio K et al (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren’s syndrome. Science 276:604–607PubMedCrossRef Haneji N, Nakamura T, Takio K et al (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren’s syndrome. Science 276:604–607PubMedCrossRef
7.
go back to reference Ruffatti A, Ostuni P, Grypiotis P et al (2004) Sensitivity and specificity for primary Sjogren’s syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 31:504–507PubMed Ruffatti A, Ostuni P, Grypiotis P et al (2004) Sensitivity and specificity for primary Sjogren’s syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 31:504–507PubMed
8.
go back to reference Szanto A, Csipo I, Zeher M (2005) Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjogren’s syndrome. J Rheumatol 32:197PubMed Szanto A, Csipo I, Zeher M (2005) Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjogren’s syndrome. J Rheumatol 32:197PubMed
9.
go back to reference Bacman S, Perez Leiros C, Sterin-Borda L et al (1998) Autoantibodies against lacrimal gland M3 muscarinic acethylcoline receptors in patients with primary Sjögren’s syndrome. Investig Ophthalmol Vis Sci 39:151–156 Bacman S, Perez Leiros C, Sterin-Borda L et al (1998) Autoantibodies against lacrimal gland M3 muscarinic acethylcoline receptors in patients with primary Sjögren’s syndrome. Investig Ophthalmol Vis Sci 39:151–156
10.
go back to reference Bacman S, Sterin-Borda L, Camusso JJ et al (1996) Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren’s syndrome. Clin Exp Immunol 104:454–459PubMedCrossRef Bacman S, Sterin-Borda L, Camusso JJ et al (1996) Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren’s syndrome. Clin Exp Immunol 104:454–459PubMedCrossRef
11.
go back to reference Markusse HM, Otten HG, Vroom TM et al (1993) Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjogren’s syndrome. Clin Immunol Immunopathol 66:26–32PubMedCrossRef Markusse HM, Otten HG, Vroom TM et al (1993) Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjogren’s syndrome. Clin Immunol Immunopathol 66:26–32PubMedCrossRef
12.
go back to reference Esch TR (2001) Pathogenetic factors in Sjogren’s syndrome: recent developments. Crit Rev Oral Biol Med 12:244–251PubMedCrossRef Esch TR (2001) Pathogenetic factors in Sjogren’s syndrome: recent developments. Crit Rev Oral Biol Med 12:244–251PubMedCrossRef
13.
go back to reference Zeher M, Szodoray P, Gyimesi E et al (1999) Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjogren’s syndrome. Arthritis Rheum 42:1673–1681PubMedCrossRef Zeher M, Szodoray P, Gyimesi E et al (1999) Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjogren’s syndrome. Arthritis Rheum 42:1673–1681PubMedCrossRef
14.
go back to reference Tsubota K, Saito I, Miyasaka N (1994) Granzyme A and perforin expressed in the lacrimal glands of patients with primary Sjögren’s syndrome. Am J Ophthalmol 117:120–121PubMed Tsubota K, Saito I, Miyasaka N (1994) Granzyme A and perforin expressed in the lacrimal glands of patients with primary Sjögren’s syndrome. Am J Ophthalmol 117:120–121PubMed
15.
go back to reference Jonsson R, Klareskog L, Bäckman K et al (1987) Expression of HLA-D locus (DP, DQ, DR) coded antigens, β2-microglobulin, and the interleukin 2 receptor in Sjögren’s syndrome. Clin Immunol Imminopathol 45:235–243CrossRef Jonsson R, Klareskog L, Bäckman K et al (1987) Expression of HLA-D locus (DP, DQ, DR) coded antigens, β2-microglobulin, and the interleukin 2 receptor in Sjögren’s syndrome. Clin Immunol Imminopathol 45:235–243CrossRef
16.
go back to reference Vitali C, Bombardieri S, Jonsson R et al (2002) European Study Group on Classification Criteria for Sjögren’s syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R et al (2002) European Study Group on Classification Criteria for Sjögren’s syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef
17.
go back to reference Bradford MM (1976) A rapid and sensitive method for the qualification of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef Bradford MM (1976) A rapid and sensitive method for the qualification of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef
18.
go back to reference Molnar I, Kaczur V, Boros A et al (1995) IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves’ disease. J Endocrinol Invest 18:408–414PubMed Molnar I, Kaczur V, Boros A et al (1995) IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves’ disease. J Endocrinol Invest 18:408–414PubMed
19.
go back to reference Towbin H, Staehelim T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354PubMedCrossRef Towbin H, Staehelim T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354PubMedCrossRef
20.
go back to reference Roland J, Hans-Jacob H, Tom PG (2000) Current concepts on diagnosis, autoantibodies and therapy in Sjögren’s syndrome. Scand J Rheumatol 29:341–348CrossRef Roland J, Hans-Jacob H, Tom PG (2000) Current concepts on diagnosis, autoantibodies and therapy in Sjögren’s syndrome. Scand J Rheumatol 29:341–348CrossRef
21.
go back to reference Jabs DA, Lee B, Whittum-Hudson JA et al (2000) Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Investig Ophthalmol Vis Sci 41:826–831 Jabs DA, Lee B, Whittum-Hudson JA et al (2000) Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Investig Ophthalmol Vis Sci 41:826–831
22.
go back to reference Manganelli P, Quaini F, Andreoli AM et al (1997) Quantitative analysis of apoptosis and bcl-2 in Sjögren’s syndrome. J Rheumatol 24:1552–1557PubMed Manganelli P, Quaini F, Andreoli AM et al (1997) Quantitative analysis of apoptosis and bcl-2 in Sjögren’s syndrome. J Rheumatol 24:1552–1557PubMed
23.
go back to reference Ohlsson M, Jonsson R, Brokstad KA (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren’s syndrome. Scand J Immunol 56:456–469PubMedCrossRef Ohlsson M, Jonsson R, Brokstad KA (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren’s syndrome. Scand J Immunol 56:456–469PubMedCrossRef
24.
go back to reference Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330PubMedCrossRef Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330PubMedCrossRef
25.
go back to reference Kuwana M, Okano T, Ogawa Y et al (2001) Autoantibodies to the amino-terminal fragment of α-fodrin expressed in glandular epithelial cells in patients with Sjögren’s syndrome. J Immunol 167:5449–5456PubMed Kuwana M, Okano T, Ogawa Y et al (2001) Autoantibodies to the amino-terminal fragment of α-fodrin expressed in glandular epithelial cells in patients with Sjögren’s syndrome. J Immunol 167:5449–5456PubMed
Metadata
Title
Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren’s syndrome
Authors
Peter Szodoray
Katalin Koczok
Antonia Szanto
Ildiko Fanny Horvath
Britt Nakken
Ildiko Molnar
Margit Zeher
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0678-y

Other articles of this Issue 2/2008

Clinical Rheumatology 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.